Another Canadian cannabis producer has hit pause on the production of certain products because of a dispute with Health Canada over what constitutes a cannabis “edible.”
Indiva Limited has been notified by Health Canada that some of its lozenge products have been improperly classified as an “extract” rather than an “edible,” the Ottawa, Ontario-based company announced Tuesday.
ADVERTISEMENT
The company said it paused production of the products in question as it consults with advisers to consider the next steps.
The distinction between “edible” and “extract” is important because any cannabis product classified as an “extract” has 100 times more allowable THC per package than a product classified as an “edible,” making it more appealing to certain consumers.
Indiva sells lozenges in packages containing up to 500 milligrams of THC.
The company has been able to do so by classifying the products as extracts, rather than edibles.
The
Read full article on Marijuana Business Daily
